TALEN

TALEN1-csf3r

ID

ZDB-TALEN-190621-1

Name

TALEN1-csf3r

Previous Names

None

Target

csf3r (1)

Target Sequence 1

5' - TGTACCAAGGGCGGATGTGT - 3'

Target Sequence 2

5' - TTCAGTTGTCAGGGTCGAAA - 3'

Disclaimer

Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.

Note

None

Genome Resources

None

Target Location

Constructs

No data available

Genomic Features

Genomic Feature	Affected Genomic Regions
mdu5	csf3r
mdu6	csf3r

Expression

Gene expression in Wild Types + TALEN1-csf3r

No data available

Phenotype

Phenotype resulting from TALEN1-csf3r

No data available

Phenotype of all Fish created by or utilizing TALEN1-csf3r

Phenotype	Fish	Conditions	Figures
common myeloid progenitor decreased amount, abnormal	csf3r^mdu5/mdu5	standard conditions	Fig. 2 from Basheer et al., 2018
granulocyte decreased amount, abnormal	csf3r^mdu5/mdu5	chemical treatment by injection: lipopolysaccharide	Fig. 5 from Basheer et al., 2018
leukocyte decreased amount, abnormal	csf3r^mdu5/mdu5	standard conditions	Fig. 2 from Basheer et al., 2018
defense response to bacterium decreased process quality, abnormal	csf3r^mdu5/mdu5	bacterial treatment by injection: Escherichia coli	Fig. 5 from Basheer et al., 2018
circulating cell neutrophil decreased amount, abnormal	csf3r^mdu5/mdu5	standard conditions	Fig. 3, Fig. 4 from Basheer et al., 2018
anatomical structure csf3r expression decreased amount, abnormal	csf3r^mdu5/mdu5	standard conditions	Fig. 2, Fig. 3 from Basheer et al., 2018
kidney neutrophil decreased amount, abnormal	csf3r^mdu5/mdu5	standard conditions	Fig. 4 from Basheer et al., 2018
granulocyte decreased amount, abnormal	csf3r^mdu5/mdu5	standard conditions	Fig. 2, Fig. 3, Fig. 5 from Basheer et al., 2018
defense response decreased process quality, abnormal	csf3r^mdu5/mdu5	chemical treatment by injection: lipopolysaccharide	Fig. 5 from Basheer et al., 2018
myeloid cell cell migration decreased process quality, abnormal	csf3r^mdu5/mdu5	standard conditions	Fig. 2 from Basheer et al., 2018
granulocyte decreased amount, abnormal	csf3r^mdu6/mdu6	chemical treatment by injection: lipopolysaccharide	Fig. 5 from Basheer et al., 2018
granulocyte decreased amount, abnormal	csf3r^mdu6/mdu6	standard conditions	Fig. 5 from Basheer et al., 2018
defense response decreased process quality, abnormal	csf3r^mdu6/mdu6	chemical treatment by injection: lipopolysaccharide	Fig. 5 from Basheer et al., 2018
kidney myeloid cell decreased amount, abnormal	csf3r^mdu5/mdu5; i114Tg	standard conditions	Fig. 4 from Basheer et al., 2018
kidney neutrophil decreased amount, abnormal	csf3r^mdu5/mdu5; i114Tg	standard conditions	Fig. 4 from Basheer et al., 2018

Citations